Skip To Main Content
Michael D Decker on Muck Rack

Michael D Decker

As seen in: Nature, ACS Publications, Baltimore Sun, Cell Press, Hartford Courant, The Lancet, Kiplinger, Billings Gazette, The Bond Buyer, Shawangunk Journal and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael D

Contact Michael D, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

ECtHR upholds an agreement to forgo reasoning in an arbitral award

|
By Michael D Decker
| schjodt.com
In the recent Jiitee Työt Oy v. Finland judgment (ECtHR, 9 June 2026), the losing party in an arbitration had waived the right to a reasoned award – but, when it lost, came back and claimed that the award violated public policy and the right to a fair trial.
Open in Who Shared Issue with article?

AI and Technology in International Arbitration

|
By Asade Pourmand, Michael D Decker
| schjodt.com
The Survey results indicate that usage is set to "boom". The most common current application was stated to be for factual and legal research, with 91% of the Survey respondents expecting to use AI for research and data analytics over the next five years. Document review and data analytics were next in line, with growing reliance predicted as available tools mature. Speed in handling large datasets and trend-spotting, and even practical gains in arbitrator due-diligence, were cited as benefits.
Open in Who Shared Issue with article?

Pain management beyond opioids: a β-arrestin2-biased allosteric GPCR modulator opens new avenues for drug development - Signal Transduction and Targeted Therapy Original

|
By Eline Pottie, Michael D Decker
| Nature Verified
A remarkable study by Guo et al., published in Cell, suggests a compelling new direction for improving pain management: biased allosteric modulation of the neurotensin receptor 1 (NTSR1), using the drug-like molecule SBI-810, promotes β-arrestin2 (βarr2) recruitment while avoiding canonical G protein signaling – thereby providing robust analgesia across a plethora of rodent models of both acute and chronic pain without impairing motor function, cognition, or causing opioid-like dependency.1,2...
Open in Who Shared View Duplicates (2) Issue with article?
See all 29 licensed articles (38 Total)